Development and Regulatory Milestones. With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [**] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone: 1. Effective Date $ 7,000,000 2. Successful Completion of On-Going Phase I/II Trial $ 10,000,000 3. [**] $ [**] [**] $ 12,500,000 [**] $ [**] 4. [**] $ [**] 5. [**] $ [**] 6. [**] $ [**] Total Development and Regulatory Milestone Payments 132,500,000
Appears in 3 contracts
Sources: License and Commercialization Agreement (Bellerophon Therapeutics, Inc.), License and Commercialization Agreement (Bellerophon Therapeutics LLC), License and Commercialization Agreement (Bellerophon Therapeutics LLC)
Development and Regulatory Milestones. With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [**] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone:
1. Effective Date $ 7,000,000
2. Successful Completion of On-Going Phase I/II Trial $ 10,000,000
3. [**] $ [**] [**] $ 12,500,000 [**] $ [**]
4. [**] $ [**]
5. [**] $ [**]
6. [**] $ [**] Total Development and Regulatory Milestone Payments 132,500,000
Appears in 2 contracts
Sources: License and Commercialization Agreement (Ikaria, Inc.), License and Commercialization Agreement (Ikaria, Inc.)
Development and Regulatory Milestones. With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [***] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone:
1. Effective Date $ 7,000,000
2. Successful Completion of On-Going Phase I/II Trial $ 10,000,000
3. [**] $ [**] [**] $ 12,500,000 [**] $ [**]
4. [**] $ [**]
5. [**] $ [**]
6. [**] $ [**] Total Development and Regulatory Milestone Payments $ 132,500,000
Appears in 2 contracts
Sources: License and Commercialization Agreement (BioLineRx Ltd.), License and Commercialization Agreement (BioLineRx Ltd.)
Development and Regulatory Milestones. With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [***] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone:
: 1. Effective Date $ 7,000,000
2. Successful Completion of On-Going Phase I/II Trial $ 10,000,000
3. [**] $ [**] [**] $ 12,500,000 [**] $ [**]
4. [**] $ [**]
5. [**] $ [**]
6. [**] $ [**] Total Development and Regulatory Milestone Payments 132,500,000
Appears in 1 contract
Sources: License and Commercialization Agreement (BioLineRx Ltd.)